Safety and Efficacy of Indomethacin for Reducing Chest Tube Duration After Coronary Artery Bypass Grafting Surgery.

Gibson, Caitlin M; Hall, Brenton; Kwon, Hyanggi Irene; Davis, Sondra; Bradford, Darien; Howard, Meredith L

Gibson, Caitlin M; Hall, Brenton; Kwon, Hyanggi Irene; Davis, Sondra; Bradford, Darien; Howard, Meredith L.

Afiliação

Gibson CM; Department of Pharmacotherapy and Outcomes Science, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, USA.
Hall B; Department of Pharmacotherapy, College of Pharmacy, University of North Texas Health Science Center, Fort Worth, TX, USA.
Kwon HI; Department of Pharmacy, JPS Health Network, Fort Worth, TX, USA.
Davis S; Department of Pharmacy, Medical City Arlington, Arlington, TX, USA.
Bradford D; Department of Pharmacy, Medical City Arlington, Arlington, TX, USA.
Howard ML; Department of Surgery, Medical City Arlington, Arlington, TX, USA.

J Pharm Technol ; 38(3): 148-154, 2022 Jun.

Article em En | MEDLINE | ID: mdl-35600275

Palavras-chave

anti-inflammatory agents; chest tubes; coronary artery bypass; indomethacin; nonsteroidal

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Idioma: En Revista: J Pharm Technol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google